Literature DB >> 22858728

Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.

Karen L Furie, Larry B Goldstein, Gregory W Albers, Pooja Khatri, Ron Neyens, Mintu P Turakhia, Tanya N Turan, Kathryn A Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22858728     DOI： 10.1161/STR.0b013e318266722a

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  68 in total

1.  Edoxaban.

Authors:  Dennis J Cada; Danial E Baker; Kyle Ingram
Journal:  Hosp Pharm       Date:  2015-07-31

2.  Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.

Authors:  Julie C Lauffenburger; Joel F Farley; Anil K Gehi; Denise H Rhoney; M Alan Brookhart; Gang Fang
Journal:  Am J Cardiol       Date:  2015-02-02       Impact factor: 2.778

3.  Interrupting anticoagulation in patients with nonvalvular atrial fibrillation.

Authors:  Scott W Yates
Journal:  P T       Date:  2014-12

4.  Physiology: Beating stroke.

Authors:  Neil Savage
Journal:  Nature       Date:  2013-01-31       Impact factor: 49.962

5.  Secondary Use of EHR: Interpreting Clinician Inter-Rater Reliability Through Qualitative Assessment.

Authors:  Sarah Mullin; Edwin Anand; Shyamashree Sinha; Buer Song; Jane Zhao; Peter L Elkin
Journal:  Stud Health Technol Inform       Date:  2017

6.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

7.  Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Authors:  Walid Amara; Sotiris Antoniou
Journal:  Eur Heart J Suppl       Date:  2016-04-21       Impact factor: 1.803

8.  Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.

Authors:  Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Robert Giugliano; Christopher B Granger; Kenneth W Mahaffey; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa-Filho; Marcia M Barbosa; Maria da Consolacao V Moreira; Renato A K Kalil; Marildes Freitas; Joao Carlos de Campos Guerra; Marcio Vinicius Lins Barros; Thiago da Rocha Rodrigues; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 9.  Advances in the Detection and Monitoring of Atrial Fibrillation for Patients with Cryptogenic Ischemic Stroke.

Authors:  Rajbeer Singh Sangha; Richard Bernstein
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

Review 10.  Oral anticoagulants in older adults with atrial fibrillation.

Authors:  Gwen M Bernacki; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.